Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (DKK)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Diabetes and Obesity Care

122B 156B 215B 272B 289B

Total Assets

- - - - -

CAPEX

- - - - -

D&A

4.9B 5.7B 8.2B 7.1B 13.06B

Operating Income

49.54B 67.4B 99.62B 128B 126B

Rare Disease

19.2B 20.54B 17.16B 18.64B 19.61B

Total Assets

- - - - -

CAPEX

- - - - -

D&A

1.13B 1.66B 1.22B 1.44B 1.6B

Operating Income

9.11B 7.41B 2.95B 620M 1.21B

Total Assets

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (DKK)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

United States of America (USA)

63.01B 84.66B 128B 167B 173B

Total Assets

- - - 57.14B 77.39B

CAPEX

- - - - -

Total Assets

- - - 177B 195B

Europe and Canada

- - - - 66.09B

Emerging Markets

- - - - 30.44B

APAC

- - - - 20.71B

Region China

16.02B 16.21B 16.69B 18.5B 18.66B

Total Assets

- - - - -

CAPEX

- - - - -

EMEA

37.71B 44.24B 50.87B 60.4B -

North America (Excl. US)

4.25B 6.45B 9.1B 10.77B -

Total Assets

- - - - -

Africa, Asia, Middle East and Oceania (AAMEO)

- - - - -

Total Assets

- - - - -

Latin America

- - - - -

Total Assets

- - - - -

Pacific

- - - - -

Total Assets

- - - - -

Japan & Korea

- - - - -

Total Assets

- - - - -

Europe

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

Rest of the World

19.81B 25.4B 28.08B 33.33B -

International Operations

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW